meRfi®-GM
HMG-CoA reductase (HMGCR) Inhibitors (Statins)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Statin therapy produces significant reductions in major vascular events irrespective of age, but there is less direct evidence of benefit among patients older than 75 years who do not already have evidence of occlusive vascular disease. This limitation is now being addressed by further trials …
References (Sources)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trialsMeta-Analysis
- Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
- Statins use and cancer: an update
- Statins: A Conceivable Remedial Role for the Regulation of Cancer Progression
- The interplay between cholesterol and breast cancer: is there a potential role for statin therapy?